Genome editing company.
Editas Medicine is building the leading genome editing company dedicated to treating patients with genetically defined diseases.
At Editas Medicine, we believe we have entered a new era in genomic medicine as the growth of genomic information in recent years has significantly expanded our understanding of genetically defined diseases. Furthermore, a new technology known as CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) has the potential to achieve accurate, directed changes in DNA and fulfill the promise that started with the sequencing of the human genome – the potential to treat diseases at their source, at the DNA level.
Visit website: https://www.editasmedicine.com/
People at Editas Medicine
Editas Medicine News
Fixing the genes to cure inherited blindness
Guardian - 04-Mar-2020
Crispr gene editing is a great but a dangerous toolRead more...
Human trials using CRISPR to cure genetically inherited blindness
Futurism - 30-Jul-2019
There are at least 13 types of LCA - this trial is aimed at treating LCA 10Read more...